Dr. Jean-Frederic Colombel

Icahn School of Medicine at Mount Sinai

TIME TO REMISSION AND RESPONSE IN ADALIMUMAB-TREATED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS FROM ULTRA 2
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
HOSPITALIZATION RATES IN PATIENTS WITH CROHN’S DISEASE AND DEEP REMISSION: DATA FROM THE 56-WEEK CHARM TRIAL
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
EFFICACY AND SAFETY OF ADALIMUMAB IN CHILDREN WITH CROHN’S DISEASE PREVIOUSLY TREATED WITH INFLIXIMAB.
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
REDUCTIONS IN CORTICOSTEROID USE IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN’S DISEASE TREATED WITH VEDOLIZUMAB
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
CD4 LYMPHOPROLIFERATIVE DISORDER OF THE INTESTINE: FEATURES AND OUTCOME
2013-01-01
English, Polyps and tumors, Abstract, Oncology, Small intestine, 2013
POST-OPERATIVE COMPLICATIONS IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED STUDY
2013-01-01
English, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
TIME TO REMISSION AND RESPONSE IN ADALIMUMAB-TREATED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS FROM ULTRA 2
2013-01-01
English, Poster, Medical management, Inflammatory bowel disease, 'IBD-ology', 2013
HIGH DOSE INFLIXIMAB IN CROHN'S DISEASE: CLINICAL EXPERIENCE, SAFETY, AND EFFICACY
2013-01-01
English, Poster, Medical management, Inflammatory bowel disease, 'IBD-ology', 2013
LONG-TERM OUTCOME OF PAEDIATRIC-ONSET ULCERATIVE COLITIS: EARLY YEARS ARE SHAPING THE FUTURE.
2013-01-01
English, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
CANCER IN ELDERLY-ONSET INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED STUDY
2013-01-01
English, Inflammatory bowel disease, Abstract, Epidemiology, 'IBD-ology', 2013
LONG-TERM SAFETY OF VEDOLIZUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS OR CROHN’S DISEASE
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
INCIDENCE OF MICROSCOPIC COLITIS IN NORTHERN FRANCE
2010-10-25
English, Abstract, 2010
NATURAL HISTORY OF EOSINOPHILIC GASTROENTERITIS
2009-01-01
English, Poster, 2009
Mucosal healing in IBD: diagnostic approach and clinical relevance
2010-01-01
English, Presentation, Clinical aspects, Medical management, Colon, Capsule Endoscopy, Inflammatory bowel disease, Colonoscopy and sigmoidoscopy, European Society of Gastrointestinal Endoscopy (ESGE), 2010
The best clinical care in IBD
2012-01-01
English, Presentation, Clinical aspects, Medical management, Colon, Inflammatory bowel disease, 2012
What's new in Gastroenterology in clinical practice in 2013?
2013-01-01
English, Presentation, Clinical aspects, Colon, Future Horizons, Inflammatory bowel disease, Small intestine, Management review, Coeliac disease (Gluten-Sensitive Enteropathy), 'IBD-ology', 2013
Dysbiosis in Inflammatory Bowel Disease - UEGF Research Prize 2009
2009-01-01
English, Presentation, Aetiology / Causes, Colon, Inflammatory bowel disease, Epidemiology, Probiotic therapy, Gut microbiota, 2009
Keeping the balance between risks and benefit
2009-01-01
English, Presentation, Clinical aspects, Medical management, Colon, Inflammatory bowel disease, 2009
COMPOSITE REMISSION MEASURES IN EARLY CROHN’S DISEASE: A POST-HOC ANALYSIS OF THE SONIC TRIAL
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
GENETICS DO NOT DRIVE P-ANCA EXPRESSION IN TWINS WITH ULCERATIVE COLITIS
2013-01-01
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
HIGH DOSE INFLIXIMAB IN CROHN’S DISEASE: CLINICAL EXPERIENCE, SAFETY, AND EFFICACY
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

English, European Crohn’s and Colitis Organisation (ECCO), 2014, IBD, Standards and Guidelines
State-of-the-art introduction
2016-10-17
English, Presentation, 2016, IBD, Immunology, Paediatrics
Use of biologics in an IBD patient with a recent cancer diagnosis: Pro and Con
2016-10-18
English, Presentation, 2016, IBD, Digestive Oncology
What to do when all biologics fail?
2016-10-18
English, Presentation, 2016, IBD, Paediatrics, Surgery
AbbVie - Are we ready to change the course of IBD?
2018-10-22
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2018, AbbVie
Amgen - The emerging treatment landscape of IBD: role of innovator biologics and biosimilars (Amgen Europe GmbH)
2018-10-23
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2018, Amgen Europe GmbH
Takeda - Histologic remission in ulcerative colitis: Are we ready? Insights from VARSITY (Takeda Pharmaceuticals International AG)
2019-10-22
English, Presentation, Industry Sponsored Symposia, Takeda Pharmaceuticals International AG, Industry Sponsored Symposia, 2019